ASTH · XBRL financial data

Astrana Health financial statements, every fiscal year

The same tables from 9 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (ASTH's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	687	774	1,144	1,387	2,035	3,182
Cost of goods and services sold	539	596	—	—	—	—
General and administrative	49	62	78	113	154	217
Operating income (loss)	81	98	104	85	89	79
Interest income	3	2	2	14	15	12
Interest expense	9	5	8	16	33	50
Other income (expense)	1	(4)	4	6	5	(3)
Income tax expense (benefit)	56	28	41	32	31	16
Net income (loss)	38	74	45	61	43	22
Earnings per share, basic USD per share	1.04	1.69	1.00	1.30	0.91	0.46
Earnings per share, diluted USD per share	1.01	1.63	0.99	1.29	0.90	0.46
Weighted average shares, basic millions of shares	37	44	45	47	48	49
Weighted average shares, diluted millions of shares	37	45	46	47	48	49

Fiscal years (ASTH's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	193	233	288	294	288	429
Marketable securities	68	53	6	2	2	—
Accounts receivable	7	11	50	—	276	374
Prepaid and other current assets	17	19	15	17	23	26
Total current assets	339	399	428	462	638	863
Property and equipment, net	—	—	—	—	14	57
Right-of-use asset	19	15	20	37	33	36
Goodwill	239	253	269	279	419	865
Total assets	817	852	966	933	1,355	2,219
Accounts payable	10	10	—	—	—	—
Current portion of long-term debt	11	1	1	20	9	48
Total current liabilities	115	115	149	219	366	615
Long-term debt	230	183	203	259	425	991
Lease liability, non-current	16	13	20	36	31	32
Total liabilities	372	336	408	523	841	1,660
Retained earnings	70	144	182	243	286	308
Total stockholders' equity	331	455	543	614	713	779
Total liabilities and equity	817	852	966	933	1,355	2,219
Common shares outstanding (cover page) millions of shares	55	56	57	55	56	56

Fiscal years (ASTH's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	38	74	45	61	43	22
Stock-based compensation	3	7	16	22	35	39
Depreciation and amortization	18	18	18	18	28	46
Net cash from operating activities	46	70	82	68	52	115
Purchases of property and equipment	1	19	23	29	8	10
Net cash from investing activities	95	17	(7)	(66)	(192)	(539)
Proceeds from issuing common stock	0	40	0	0	—	—
Share repurchases	1	6	9	10	1	26
Dividends paid	51	31	14	62	4	8
Repayments of long-term debt	0	—	—	—	—	—
Net cash from financing activities	(52)	(48)	(20)	3	135	569
Net change in cash	90	39	55	6	(5)	145

SIC 8742 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8742 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Astrana Health	401	973	33*	55.7M	—	Q2 FY26 10-QJun 30, 2026
Evolent Health	116	653	(9.3)*	113.1M	12.4 quarters	Q2 FY26 10-QJun 30, 2026
ICF International	4.6	474	100*	17.9M	—	Q2 FY26 10-QJun 30, 2026
Onterris	13	187	6.2*	35.1M	—	Q2 FY26 10-QJun 30, 2026
V2X	265	1,271	67*	31.4M	—	Q3 FY26 10-QOct 2, 2026
Premier	43	240	16	82.7M	—	Q1 FY26 10-QSep 30, 2025
TSS	68	35	7.6*	28.2M	—	Q2 FY26 10-Q/AJun 30, 2026
Huron Consulting Group	26	491	57*	15.8M	—	Q3 FY26 10-QSep 30, 2026
Hackett Group	14	69	15*	24.9M	—	Q2 FY26 10-QJun 26, 2026

Not investment advice. Not affiliated with the U.S. SEC.